Medtronic (MDT) Tops Q2 EPS by 3c; Nudges FY16 EPS Midpoint Higher
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $92.13 -0.69%
Revenue Growth %: +5.3%
Financial Fact:
Basic weighted average shares outstanding: 983.8M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +5.3%
Financial Fact:
Basic weighted average shares outstanding: 983.8M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q2 EPS of $1.03, $0.03 better than the analyst estimate of $1.00. Revenue for the quarter came in at $7.1 million versus the consensus estimate of $7.06 million.
GUIDANCE:
Medtronic sees FY16 EPS of $4.33-$4.40, versus prior guidance of $4.30-$4.40 and the consensus of $4.36.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
